Who we are

What is VPH

VPH – The Society for In Silico Medicine is an international scientific community with the mission to advance in silico medicine worldwide. As an ecosystem organisation, our vision is to bring together diverse stakeholder communities of scientists, industry, healthcare providers, patients, regulators, and policymakers to drive the development and integration of computer models in healthcare for the benefit of all.

Our Members

Our members are both individuals and organisations who share the common goal of making in silico medicine a reality in all aspects of health and care.

 

  • Personal

    Personal members are individual researchers and professionals.

  • Student

    Student members are enrolled in undergraduate, graduate, or doctoral programs.

  • Ordinary

    Organisations and research groups. This membership is open to all individuals affiliated with their institution.

  • Supporting

    Ordinary members with the additional opportunity to engage at a strategic level and be eligible to join VPH Board of Directors.

Read more

Avicenna Alliance

VPH also represents the academic community inside the Avicenna Alliance, an industry-academia network promoting the use of in silico medicine technologies in healthcare.

The Alliance is composed of two equal pillars: the VPH community, representing the academic voice, and the industrial sector, encompassing leading companies active in the field. Our shared mission is to establish in silico medicine as a standard practice in healthcare, enhancing innovation, safety, and efficiency in medical research and treatment.

Go to website

History of VPH

  • 2001

    The IUPS Physiome Project

    The International Union of Physiological Sciences launches the Physiome Project founded on the idea that the quantitative and integrated understanding of the physiological dynamics of a normal, intact organism can be systematically explored.

  • 2005

    The Virtual Physiological Human (VPH)

    The Virtual Physiological Human initiative is established as the European counterpart to the Physiome Project, aiming to develop integrative computational models of human physiology.

  • 2007

    Seeding the EuroPhysiome

    The STEP consortium publishes a landmark consensus document titled “Seeding the EuroPhysiome: A Roadmap to the Virtual Physiological Human”. where for the first time the community expresses the need to create a European institute dedicated to the VPH, as a means to ensure long-term sustainability.

  • January
    2010

    Community Support

    A public petition is organised to gauge the scientific community’s support for the creation of a VPH Institute. Nearly 300 experts from over 30 countries sign in favor of the initiative.

  • September
    2010

    The VPH Consensus Meeting

    At the 2010 VPH Consensus Meeting, the incorporation of the VPH Institute is discussed in detail. The draft statute is presented, defining membership types and the proposed governance model.

  • 2011

    The Incorporation of the VPH Institute

    On 16 May 2011, the Virtual Physiological Human Institute for Integrative Biomedical Research is officially established as a legal entity with ten founding member institutions on board.

    On 1 June 2011, the institute officially began its operations.

  • 2015

    The Avicenna Roadmap

    The EU-funded CSA, Avicenna, delivers the Avicenna Roadmap. Its goal is to define a research and technological development strategy for In Silico Clinical Trials (ISCT).
    The VPH is one of the project partners, alongside the University of Sheffield, Lynkeus, and Obsidian.

  • 2016

    The Avicenna Alliance

    After publishing the Roadmap, the European Commission tasks the VPH institute with creating an industry–academia partnership to accelerate VPH technology adoption. In 2016, VPH founded the Avicenna Alliance, equally representing academia and industry across medical, pharma, software, and cosmetics sectors.

  • 2021

    Advancing In Silico Innovation through EU Collaboration

    VPH actively engages in EU-funded H2020 initiatives, leading to its participation in three major consortia from the same call — In Silico World, SIMCor, and SimCardioTest — all driving forward the adoption of in silico medicine.

  • 2023

    The European Virtual Human Twins Initiative

    In December 2023, the European Commission launches the European Virtual Human Twins Initiative to advance collaborative research using AI and supercomputing. This effort enables large-scale simulations and accelerates VHT development through AI models for human health and disease.

  • 2025

    The EDITH Roadmap

    The EDITH-CSA, coordinated by VPH, delivers a comprehensive roadmap that outlines the essential components and strategies for the successful development, integration, and implementation of the Virtual Human Twin.